loadpatents
Patent applications and USPTO patent grants for Fischmann; Thierry O..The latest application filed is for "anti-human pd-1 antibody crystals and methods of use thereof".
Patent | Date |
---|---|
Anti-human Pd-1 Antibody Crystals And Methods Of Use Thereof App 20210317215 - Reichert; Paul ;   et al. | 2021-10-14 |
Anilinopiperazine derivatives and methods of use thereof Grant 9,206,142 - Shipps, Jr. , et al. December 8, 2 | 2015-12-08 |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Grant 8,673,924 - Guzi , et al. March 18, 2 | 2014-03-18 |
MEK1 polypeptides Grant 8,440,443 - Fischmann , et al. May 14, 2 | 2013-05-14 |
Anilinopiperazine Derivatives And Methods Of Use Thereof App 20120328691 - Shipps, JR.; Gerald W. ;   et al. | 2012-12-27 |
2-aminothiazole-4-carboxylic amides as protein kinase inhibitors Grant 8,318,735 - Shipps, Jr. , et al. November 27, 2 | 2012-11-27 |
2-aminothiazole-4-carboxylic amides as protein kinase inhibitors Grant 8,227,605 - Shipps, Jr. , et al. July 24, 2 | 2012-07-24 |
Kinase domain polypeptide of human protein kinase B gamma (AKT3) Grant 8,088,611 - Prongay , et al. January 3, 2 | 2012-01-03 |
Method for crystallizing aurora 2 kinase catalytic domain polypeptide Grant 7,824,491 - Fischmann , et al. November 2, 2 | 2010-11-02 |
Akt3 Polypeptides App 20100267053 - PRONGAY; ANDREW J. ;   et al. | 2010-10-21 |
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,807,683 - Guzi , et al. October 5, 2 | 2010-10-05 |
Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3) Grant 7,776,589 - Prongay , et al. August 17, 2 | 2010-08-17 |
2-aminothiazole-4-carboxylic Amides As Protein Kinase Inhibitors App 20100130465 - Shipps, JR.; Gerald W. ;   et al. | 2010-05-27 |
2-aminothiazole-4-carboxylic Amides As Protein Kinase Inhibitors App 20100055090 - Shipps, JR.; Gerald W. ;   et al. | 2010-03-04 |
Kinase inhibitors Grant 7,528,132 - Chan , et al. May 5, 2 | 2009-05-05 |
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,514,442 - Guzi , et al. April 7, 2 | 2009-04-07 |
High affinity quinoline-based kinase ligands Grant 7,511,063 - Deng , et al. March 31, 2 | 2009-03-31 |
Crystalline Form Of The Catalytic Domain Of Aurora 2 Kinase And Methods Of Use Thereof App 20090081706 - Fischmann; Thierry O. ;   et al. | 2009-03-26 |
Crystalline form of the catalytic domain of Aurora 2 kinase and methods of use thereof Grant 7,422,885 - Fischmann , et al. September 9, 2 | 2008-09-09 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20080050384 - Guzi; Timothy J. ;   et al. | 2008-02-28 |
Novel high affinity quinoline-based kinase ligands App 20080045568 - Deng; Yongqi ;   et al. | 2008-02-21 |
Kinase inhibitors App 20080004257 - Chan; Tin-Yau ;   et al. | 2008-01-03 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054925 - Guzi; Timothy J. ;   et al. | 2007-03-08 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054906 - Guzi; Timothy J. ;   et al. | 2007-03-08 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070037824 - Guzi; Timothy J. ;   et al. | 2007-02-15 |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,161,003 - Guzi , et al. January 9, 2 | 2007-01-09 |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,119,200 - Guzi , et al. October 10, 2 | 2006-10-10 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060178371 - Guzi; Timothy J. ;   et al. | 2006-08-10 |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,067,661 - Guzi , et al. June 27, 2 | 2006-06-27 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040209878 - Guzi, Timothy J. ;   et al. | 2004-10-21 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040106624 - Guzi, Timothy J. ;   et al. | 2004-06-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.